Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.05.02.20088872: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization Our objective was to identify all randomized clinical trials (RCTs) that compared the safety profiles of chloroquine or hydroxychloroquine with placebo or other active agents. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources We searched PubMed, MEDLINE, Cochrane, the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, and the ClinicalTrials.gov for all the RCTs comparing CQ or HCQ with placebo or other active agents, published before March 31, 2020. PubMedsuggested: (PubMed, RRID:SCR_004846)MEDLINEsuggested: (MEDLINE, RRID:SCR…SciScore for 10.1101/2020.05.02.20088872: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization Our objective was to identify all randomized clinical trials (RCTs) that compared the safety profiles of chloroquine or hydroxychloroquine with placebo or other active agents. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources We searched PubMed, MEDLINE, Cochrane, the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, and the ClinicalTrials.gov for all the RCTs comparing CQ or HCQ with placebo or other active agents, published before March 31, 2020. PubMedsuggested: (PubMed, RRID:SCR_004846)MEDLINEsuggested: (MEDLINE, RRID:SCR_002185)Cochranesuggested: (Cochrane Library, RRID:SCR_013000)Cochrane Central Register of Controlled Trialssuggested: (Cochrane Central Register of Controlled Trials, RRID:SCR_006576)EMBASEsuggested: (EMBASE, RRID:SCR_001650)Medical subject headings (MeSH terms) and keywords such as “randomized controlled trial,” “adverse effects,” “tolerability,” “toxicity,” and “side effects” were used. MeSHsuggested: (MeSH, RRID:SCR_004750)Study Quality Assessment and Risk of Bias: Risk of bias in the individual studies included for meta-analysis was assessed using the Cochrane risk assessment tool. Cochrane risk assessment toolsuggested: NoneAll analyses were performed using STATA 16 (Stata, College Station, TX, USA). STATAsuggested: (Stata, RRID:SCR_012763)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-